DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$72.1M |
| 2 |
Indivior
INDV
|
$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$45.7M |
| 4 |
Merus
MRUS
|
$32.9M |
| 5 |
Viatris
VTRS
|
$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$102M |
| 2 |
Surgery Partners
SGRY
|
$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$57.6M |
| 4 |
BioNTech
BNTX
|
$49.8M |
| 5 |
Integra LifeSciences
IART
|
$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Absci
ABSI
$368M
| $1.01M | 0.02% |
265,382
+82,289
| +45% | +$314K |
|
127
Nu Skin
NUS
$565M
| $1.01M | 0.02% |
137,145
+123,692
| +919% | +$912K |
|
128
Barings BDC
BBDC
$984M
| $1M | 0.01% |
102,058
+85,288
| +509% | +$836K |
|
129
Upbound Group
UPBD
$1.45B
| $992K | 0.01% |
+31,004
| New | +$992K |
|
130
National Vision
EYE
$1.85B
| $983K | 0.01% |
+90,091
| New | +$983K |
|
131
Global Payments
GPN
$21.1B
| $981K | 0.01% |
+9,580
| New | +$981K |
|
132
WaFd
WAFD
$2.5B
| $976K | 0.01% |
+28,005
| New | +$976K |
|
133
Nutanix
NTNX
$18.7B
| $973K | 0.01% |
16,429
+2,222
| +16% | +$132K |
|
|
AMED
134
DELISTED
Amedisys
AMED
| $972K | 0.01% |
+10,072
| New | +$972K |
|
135
Kulicke & Soffa
KLIC
$1.99B
| $972K | 0.01% |
+21,531
| New | +$972K |
|
136
Xcel Energy
XEL
$42.9B
| $965K | 0.01% |
+14,782
| New | +$965K |
|
137
HealthEquity
HQY
$7.9B
| $964K | 0.01% |
+11,781
| New | +$964K |
|
138
CareDx
CDNA
$732M
| $964K | 0.01% |
+30,871
| New | +$964K |
|
139
Merck
MRK
$211B
| $963K | 0.01% |
+8,482
| New | +$963K |
|
140
Banc of California
BANC
$2.66B
| $960K | 0.01% |
+65,140
| New | +$960K |
|
141
Zscaler
ZS
$42.3B
| $957K | 0.01% |
+5,600
| New | +$957K |
|
142
Helios Technologies
HLIO
$1.83B
| $954K | 0.01% |
+19,995
| New | +$954K |
|
|
PPBI
143
DELISTED
Pacific Premier Bancorp
PPBI
| $949K | 0.01% |
+37,705
| New | +$949K |
|
144
Gorman-Rupp
GRC
$1.13B
| $945K | 0.01% |
+24,253
| New | +$945K |
|
145
Adobe
ADBE
$148B
| $944K | 0.01% |
1,823
-137
| -7% | -$70.9K |
|
146
Capital One
COF
$142B
| $942K | 0.01% |
+6,291
| New | +$942K |
|
147
ADMA Biologics
ADMA
$4.04B
| $940K | 0.01% |
47,016
-12,204
| -21% | -$244K |
|
148
Carpenter Technology
CRS
$12.3B
| $936K | 0.01% |
+5,864
| New | +$936K |
|
149
Alamo Group
ALG
$2.54B
| $927K | 0.01% |
+5,148
| New | +$927K |
|
|
PETQ
150
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $926K | 0.01% |
+30,082
| New | +$926K |
|